Benjamin F. Cravatt
Board Member
Alnylam Pharmaceuticals, Inc. (ALNY)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Benjamin F. Cravatt
Benjamin F. Cravatt is recorded as Board Member at Alnylam Pharmaceuticals, Inc. (ALNY). Alnylam Pharmaceuticals, Inc. reported in an 8-K filed May 27, 2026 that Benjamin F. Cravatt was appointed Class III director, effective June 1, 2026.
“Effective as of June 1, 2026, the Board of Directors (the "Board") of Alnylam Pharmaceuticals, Inc. (the "Company"), following the recommendation of its Nominating and Corporate Governance Committee, expanded the size of the Company's Board from ten to eleven and elected Benjamin F. Cravatt, Ph.D. to fill the newly created vacancy.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2026-06-01–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Alnylam Pharmaceuticals, Inc.
Other people whose current roles at this company are on record from its filings.
- Yvonne Greenstreet CEO, COO
- Yvonne L. Greenstreet CEO, COO, Board Member
- Amy W. Schulman Chairman, Board Member
- Michael Bonney Chairman
- Michael W. Bonney Chairman
- Jeffrey Poulton CFO
- Manmeet S CFO
- Akshay K. Vaishnaw, M.D., Ph.D. CIO
- Benjamin F. Cravatt, Ph.D. Board Member
- Carolyn R. Bertozzi Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.